導(dǎo)師簡介

姓名： 薛慧如性別： 女政治面貌：中共黨員

學(xué)歷：博士學(xué)位：博士職稱： 副主任醫(yī)師

博、碩導(dǎo)師：碩導(dǎo)本崗位工作年數(shù)：18年

研究方向：神經(jīng)免疫

榮譽(yù)稱號：

山西省“三晉英才”支持計劃青年優(yōu)秀人才

英國牛津大學(xué)John Radcliffe Hospital訪問學(xué)者

學(xué)術(shù)任職：

中國卒中學(xué)會免疫分會委員

山西省醫(yī)學(xué)會神經(jīng)病學(xué)專委會神經(jīng)感染免疫學(xué)組副組長

山西省免疫學(xué)會神經(jīng)免疫專委會秘書

山西省免疫學(xué)會神經(jīng)感染免疫專委會常委

山西省老年醫(yī)學(xué)學(xué)會老年神經(jīng)醫(yī)學(xué)委員會常委

山西省醫(yī)師協(xié)會神經(jīng)內(nèi)科醫(yī)師分會委員

山西省健康協(xié)會神經(jīng)病學(xué)分會委員

近五年承擔(dān)科研課題情況：

山西省科技廳青年自然研究基金,項目名稱： 視神經(jīng)脊髓炎晝夜節(jié)律紊亂特征及其機(jī)制的實驗研究,項目編號：201901D211487

山西省科技廳面上自然研究基金,項目名稱： 星形膠質(zhì)細(xì)胞在視神經(jīng)脊髓炎晝夜節(jié)律紊亂中的調(diào)控機(jī)制研究,編號：202403021221299

代表性論著及近五年的代表性論文（限10項以內(nèi)）：

1.Xue H, Wu M, Wang Y, Zhao Y, Zhang M, Zhang H. The circadian rhythms regulated by Cx43-signaling in the pathogenesis of Neuromyelitis Optica. Front Immunol. 2023 Jan 16;13:1021703. doi: 10.3389/fimmu.2022.1021703. PMID: 36726988; PMCID: PMC9885795.

2.Xue H, Yang W, Zhao Y, Wang L, Wang G, Zhang M, Zhang H. Pain in neuromyelitis optic spectrum disorder. Mult Scler Relat Disord. 2022 Dec;68:104192. doi: 10.1016/j.msard.2022.104192. Epub 2022 Sep 23. PMID: 36244188.

3.Xue H, Yang Z, Wang L, Jiang Y, Li J, Wu M, Wang G, Zhang Y, Zhang M. Factors Influencing the Degree of Disability in Patients With Multiple Sclerosis. Front Neurol. 2021 Oct 13;12:714631. doi: 10.3389/fneur.2021.714631. PMID: 34721257; PMCID: PMC8548829.

4.Xue H, Cao X, Zhang M. Alteration of Circadian Rhythms in 2D2 Transgenic Mice. Med Sci Monit. 2018 Nov 17;24:8272-8278. doi: 10.12659/MSM.908528. PMID: 30447063; PMCID: PMC6252048.

5.Wang M, Zeng P, Du C,Xue H, Cui Z, Zhang H, Jia D, Zhang C. Differential efficacy of mycophenolate mofetil in adults with relapsing myelin oligodendrocyte glycoprotein antibody-associated disorders. Mult Scler Relat Disord. 2021 Aug;53:103035. doi: 10.1016/j.msard.2021.103035. Epub 2021 May 24. PMID: 34077831.

6.Li H, Huang Z, Jia D,Xue H, Pan J, Zhang M, Shi K, Shi FD, Zhang C. Low-dose rituximab treatment for new-onset generalized myasthenia gravis. J Neuroimmunol. 2021 May 15;354:577528. doi: 10.1016/j.jneuroim.2021.577528. Epub 2021 Feb 24. PMID: 33662696.

7.Zhang M, Zhang C, Bai P,Xue H, Wang G. Effectiveness of low dose of rituximab compared with azathioprine in Chinese patients with neuromyelitis optica: an over 2-year follow-up study. Acta Neurol Belg. 2017 Sep;117(3):695-702. doi: 10.1007/s13760-017-0795-6. Epub 2017 Jun 12. PMID: 28608315.

8.Guo J, Wu J, Wang L, Liu H, Wu X, Yang H, Li W, Wang H, Bu B, Yang C, Zhou H, Guo S, Zhao Y, Wang Z, Li C, Tian DC, Chen S,Xue H, Zhang Y, Xu Y, Liang H, Wu Z, Zhang Y, Dong Q, Wang J, Quan C. Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China. Ther Adv Neurol Disord. 2024 Apr 13;17:17562864241239117. doi: 10.1177/17562864241239117. PMID: 38616782; PMCID: PMC11015775.

9.Li Y, Zhao R, Li L,Xue H, Meng H, Li G, Liang F, Zhang H, Ma J, Pang X, Wang J, Chang X, Guo J, Zhang W. Relative frequencies and clinical features of Guillain-BarréSyndrome before and during the COVID-19 pandemic in North China. BMC Infect Dis. 2024 May 30;24(1):541. doi: 10.1186/s12879-024-09401-1. PMID: 38816802; PMCID: PMC11138026.